Search Results - "Stefani, Stephen"
-
1
Cancer control in Latin America and the Caribbean: recent advances and opportunities to move forward
Published in The lancet oncology (01-11-2021)“…The increasing burden of cancer represents a substantial problem for Latin America and the Caribbean. Two Lancet Oncology Commissions in 2013 and 2015…”
Get full text
Journal Article -
2
The burden of systemic therapy administration route in treating HER2-positive breast cancer (for patients, healthcare professionals, and healthcare system): a systematic literature review
Published in Frontiers in pharmacology (19-08-2024)“…Breast cancer (BC) is one of the leading causes of cancer and is the first cause of death from malignant tumors among women worldwide. New cancer therapies…”
Get full text
Journal Article -
3
The Value of Biomarkers in Optimizing the Use of Immuno-oncologic Therapy
Published in Current drug targets (01-01-2019)“…The development of therapies that restore or activate the host immune response - the socalled "immuno-oncologic" therapy - has improved the survival of some…”
Get more information
Journal Article -
4
Brazilian health-care policy for targeted oncology therapies and companion diagnostic testing
Published in The lancet oncology (01-08-2016)“…Summary A growing understanding of the molecular pathology of tumours combined with a surge of new drugs and associated diagnostic technologies (ie, precision…”
Get full text
Journal Article -
5
Correction: BRAF Testing in Melanoma and Colorectal Cancer in Latin America: Challenges and Opportunities
Published in Curēus (Palo Alto, CA) (01-12-2022)“…[This corrects the article DOI: 10.7759/cureus.31972.]…”
Get full text
Journal Article -
6
BRAF Testing in Melanoma and Colorectal Cancer in Latin America: Challenges and Opportunities
Published in Curēus (Palo Alto, CA) (28-11-2022)“…The incidence of colorectal cancer in Argentina and Brazil has reached levels comparable to those in higher-income countries. Similarly, the incidence of…”
Get full text
Journal Article -
7
Fighting Cancer around the World: A Framework for Action
Published in Healthcare (Basel) (25-10-2022)“…Tackling cancer is a major challenge right on the global level. Europe is only the tip of an iceberg of cancer around the world. Prosperous developed countries…”
Get full text
Journal Article -
8
Correction to: A call to action: molecular pathology in Brazil
Published in Surgical and experimental pathology (17-11-2021)Get full text
Journal Article -
9
A call to action: molecular pathology in Brazil
Published in Surgical and experimental pathology (11-10-2021)“…Abstract Background Adoption of molecular pathology in Brazil is currently very limited. Of note, there are no programs for training new molecular pathologists…”
Get full text
Journal Article -
10
More Doctors: Thoughts about a Controversial Health Care Policy
Published in Value in health regional issues (01-12-2014)Get full text
Journal Article -
11
A preferência de profissionais de saúde e pacientes pela via de administração da terapia sistêmica no tratamento do câncer de mama HER2-positivo: uma revisão sistemática da literatura
Published in Jornal de Assistência Farmacêutica e Farmacoeconomia (08-11-2023)“…Introdução: O câncer de mama (CM) é um dos tipos de câncer mais prevalentes e é a primeira causa de morte por tumores malignos entre as mulheres em todo o…”
Get full text
Journal Article -
12
Framework for Adoption of Next-Generation Sequencing (NGS) Globally in the Oncology Area
Published in Healthcare (Basel) (01-02-2023)“…Radical new possibilities of improved treatment of cancer are on offer from an advanced medical technology already demonstrating its significance:…”
Get full text
Journal Article -
13
Is Equity of Access to Health Care Achievable in Latin America?
Published in Value in health (01-07-2011)Get full text
Journal Article -
14
Evolution of cancer treatment costs in the last 36 months in a self-funded health care in Brazil
Published in Journal of clinical oncology (01-06-2023)“…e18838 Background: In Brazil, cancer, in addition to being one of the main causes of illness and death, represents one of the highest public and private…”
Get full text
Journal Article -
15
Cost-minimisation analysis of erlotinib in the second-line treatment of non-small-cell lung cancer: a Brazilian perspective
Published in Journal of medical economics (2008)“…A cost-minimisation and budget impact analysis of erlotinib versus docetaxel or pemetrexed as second-line treatment for advanced non-small-cell lung cancer…”
Get more information
Journal Article -
16
Delivering precision oncology to patients with cancer
Published in Nature Medicine (01-04-2022)“…With the increasing use of genomic profiling for diagnosis and therapy guidance in many tumor types, precision oncology is rapidly reshaping cancer care…”
Get full text
Journal Article Magazine Article -
17
Enhancing colon cancer care in restricted-resource settings
Published in The lancet oncology (01-06-2023)“…Colon cancer ranks third among the most frequently diagnosed cancers worldwide and was projected to claim more than 900 000 lives in 2020, according to the…”
Get full text
Journal Article -
18
All-cause and cancer mortality in a private health plan in Brazil: Ten years retrospective analysis
Published in Journal of clinical oncology (20-05-2020)“…Abstract only e13610 Background: Cancer is the second leading cause of death worldwide. From 2014 to 2015 Brazil estimated more than 500,000 new cases of…”
Get full text
Journal Article -
19
Adverse event management costs for first-line treatment with cetuximab or panitumumab of RAS wild-type metastatic colorectal cancer patients in Latin America
Published in Journal of clinical oncology (01-02-2022)“…Abstract only 203 Background: Anti-EGFR treatment of RAS wild-type metastatic colorectal cancer (mCRC) in Latin America includes cetuximab or panitumumab,…”
Get full text
Journal Article -
20
Cost-effectiveness of ribociclib plus letrozole versus palbociclib plus letrozole or letrozole as monotherapy in first-line treatment of postmenopausal women with HR+/HER2− locally advanced or metastatic breast cancer: a Brazilian private payer perspective
Published in Therapeutic advances in medical oncology (2021)“…Background: The global burden of breast cancer (BC) is high, especially in advanced stages. CDK 4/6 inhibitors represent a paradigm shift in the treatment of…”
Get full text
Journal Article